Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00264914 | Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion | PHASE3 | COMPLETED | 57 | — | — | Jul 1, 2005 | Aug 1, 2007 | Jan 21, 2009 | 11 | United States, Australia +9 |
| NCT00264927 | Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion | PHASE3 | COMPLETED | 77 | — | — | May 1, 2004 | Sep 1, 2007 | Dec 10, 2008 | 11 | United States, Belgium +9 |
| Name | Type | Description |
|---|---|---|
| SR121463B | DRUG | - |
Inclusion Criteria: * Male or female patients aged 18 years and higher. * SIADH (the diagnosis of SIADH is based on several criteria including true serum hypoosmolality, inappropriate urinary osmolality, clinical euvolemia, elevated urinary sodium excretion while on normal salt and water intake, an...